CY2016027I1 - Πολυμερικες ενωσεις πολυαλκυλενιου και χρησεις αυτων - Google Patents
Πολυμερικες ενωσεις πολυαλκυλενιου και χρησεις αυτωνInfo
- Publication number
- CY2016027I1 CY2016027I1 CY2016027C CY2016027C CY2016027I1 CY 2016027 I1 CY2016027 I1 CY 2016027I1 CY 2016027 C CY2016027 C CY 2016027C CY 2016027 C CY2016027 C CY 2016027C CY 2016027 I1 CY2016027 I1 CY 2016027I1
- Authority
- CY
- Cyprus
- Prior art keywords
- polymer compounds
- polyalkylene polymer
- polyalkylene
- compounds
- polymer
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 229920001281 polyalkylene Polymers 0.000 title 1
- 229920000642 polymer Polymers 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/329—Polymers modified by chemical after-treatment with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/31—Somatostatins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/34—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from hydroxy compounds or their metallic derivatives
- C08G65/48—Polymers modified by chemical after-treatment
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L71/00—Compositions of polyethers obtained by reactions forming an ether link in the main chain; Compositions of derivatives of such polymers
- C08L71/02—Polyalkylene oxides
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L2203/00—Applications
- C08L2203/02—Applications for biomedical use
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Polymers & Plastics (AREA)
- Neurology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Hematology (AREA)
- Psychiatry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Pulmonology (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hospice & Palliative Care (AREA)
- Medicinal Preparation (AREA)
- Polyethers (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34991702P | 2002-01-18 | 2002-01-18 | |
| PCT/US2003/001559 WO2003061577A2 (en) | 2002-01-18 | 2003-01-17 | Polyalkylene glycol with moiety for conjugating biologically active compound |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CY2016027I2 CY2016027I2 (el) | 2017-06-28 |
| CY2016027I1 true CY2016027I1 (el) | 2017-06-28 |
Family
ID=27613339
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY2016027C CY2016027I1 (el) | 2002-01-18 | 2016-08-05 | Πολυμερικες ενωσεις πολυαλκυλενιου και χρησεις αυτων |
| CY20201100115T CY1122841T1 (el) | 2002-01-18 | 2020-02-06 | Πολυαλκυλενικες πολυμερικες ενωσεις και χρησεις αυτων |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20201100115T CY1122841T1 (el) | 2002-01-18 | 2020-02-06 | Πολυαλκυλενικες πολυμερικες ενωσεις και χρησεις αυτων |
Country Status (35)
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20150246097A9 (en) * | 2002-01-18 | 2015-09-03 | Biogen Idec Ma Inc. | Polyalkylene Polymer Compounds and Uses Thereof |
| HUE047557T2 (hu) * | 2002-01-18 | 2020-04-28 | Biogen Ma Inc | Polialkilén polimervegyületek és felhasználásuk |
| WO2004022630A2 (en) | 2002-09-09 | 2004-03-18 | Nektar Therapeutics Al, Corporation | Water-soluble polymer alkanals |
| US8129330B2 (en) | 2002-09-30 | 2012-03-06 | Mountain View Pharmaceuticals, Inc. | Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof |
| PT1667708E (pt) * | 2002-12-26 | 2012-09-14 | Mountain View Pharmaceuticals | Conjugados de interferão-beta-1b e polietileno glicol apresentando uma potência biológica in vitro aumentada |
| MXPA05006945A (es) * | 2002-12-26 | 2005-12-14 | Mountain View Pharmaceuticals | Conjugados polimericos de citoquinas, quimiocinas, factores de crecimiento, hormonas polipeptidicas y sus antagonistas con actividad conservada de union al receptor. |
| CA2509153C (en) | 2002-12-31 | 2013-04-16 | Nektar Therapeutics Al, Corporation | Hydrolytically stable maleimide-terminated polymers |
| US7432331B2 (en) | 2002-12-31 | 2008-10-07 | Nektar Therapeutics Al, Corporation | Hydrolytically stable maleimide-terminated polymers |
| AR047552A1 (es) | 2003-06-26 | 2006-01-25 | Control Delivery Sys Inc | Sistemas de suministro de farmacos de liberacion sostenida biodegradables |
| CN101862455A (zh) | 2003-06-26 | 2010-10-20 | 普西维达公司 | 原位胶凝的药物递送系统 |
| EP1758583A2 (en) * | 2004-05-31 | 2007-03-07 | Ranbaxy Laboratories Limited | Arylpiperazine derivatives useful as adrenergic receptor antagonists |
| AU2005318984B2 (en) | 2004-12-21 | 2011-12-01 | Nektar Therapeutics | Stabilized polymeric thiol reagents |
| US20070004635A1 (en) * | 2005-06-02 | 2007-01-04 | Schering Corporation | Method of treating interferon non-responders using HCV protease inhibitor |
| BRPI0612407A2 (pt) | 2005-07-08 | 2010-11-03 | Elan Pharm Inc | preparação de conjugados poliméricos de compostos terapêuticos, agrìcolas e aditivos alimentìcios |
| MX2008014520A (es) * | 2006-05-22 | 2008-11-27 | Elan Pharm Inc | Preparacion de conjugados polimericos de compuestos terapeuticos, agricolas, y de aditivos para alimentos. |
| WO2008066816A2 (en) * | 2006-11-28 | 2008-06-05 | The Board Of Trustees Of The University Of Illinois | Derivatization or ligaton of peptides |
| EP2175878A4 (en) * | 2007-07-11 | 2014-12-03 | Belrose Pharma Inc | POLYMER DRUG DISPENSING SYSTEM WITH A MULTIPLE SUBSTITUTED AROMATIC PART |
| TW200922623A (en) * | 2007-07-11 | 2009-06-01 | Enzon Pharmaceuticals Inc | Polymeric drug delivery systems containing an aromatic allylic acid |
| CL2008002399A1 (es) * | 2007-08-16 | 2009-01-02 | Pharmaessentia Corp | Conjugado sustancialmente puro que posee una porcion polimerica, una porcion proteica (interferon alfa 2b) y un ligante alifatico de 1 a 10 atomos de carbono, util en el tratamiento de las hepatitis b o c. |
| WO2009149377A1 (en) * | 2008-06-05 | 2009-12-10 | Zymogenetics, Llc | Use of pegylated type iii interferons for the treatment of hepatitis c |
| US8273343B2 (en) * | 2008-07-31 | 2012-09-25 | Pharmaessentia Corp. | Protein-polymer conjugates |
| GB0823309D0 (en) | 2008-12-19 | 2009-01-28 | Univ Bath | Functionalising reagents and their uses |
| JPWO2010140350A1 (ja) | 2009-06-02 | 2012-11-15 | パナソニック株式会社 | ダウンミックス装置、符号化装置、及びこれらの方法 |
| UA109646C2 (uk) * | 2009-12-10 | 2015-09-25 | Терапевтичне застосування кон'югатів білка з полімером | |
| US20130225789A1 (en) * | 2012-02-29 | 2013-08-29 | Yi Sun | Polyethylene Glycol Having Hetero Multiple Functional Groups |
| US8993614B2 (en) | 2012-03-15 | 2015-03-31 | F. Hoffmann-La Roche Ag | Substituted pyrrolidine-2-carboxamides |
| KR101475630B1 (ko) * | 2013-05-31 | 2014-12-22 | 동국대학교 산학협력단 | 포도근 추출물 또는 이의 분획물을 유효성분으로 포함하는 c형 간염의 예방 또는 치료용 조성물 |
| US11759500B2 (en) * | 2014-07-24 | 2023-09-19 | Abion Inc. | PEGylated interferon-beta variant |
| DK3183264T3 (da) * | 2014-08-19 | 2020-11-02 | Biogen Ma Inc | Pegyleringsfremgangsmåde |
| GB201419108D0 (en) | 2014-10-27 | 2014-12-10 | Glythera Ltd | Materials and methods relating to linkers for use in antibody drug conjugates |
| FI3215193T3 (fi) | 2014-11-06 | 2023-12-28 | Pharmaessentia Corp | Pegyloidun interferonin annostusohjelma |
| ES2831079T3 (es) * | 2017-06-28 | 2021-06-07 | Construction Research & Technology Gmbh | Dispersante para partículas inorgánicas |
| US11472894B2 (en) | 2018-07-23 | 2022-10-18 | Carnegie Mellon University | Enzyme-assisted ATRP procedures |
| WO2020028715A1 (en) | 2018-08-01 | 2020-02-06 | Russell Alan J | Amino-reactive positively charged atrp initiators that maintain their positive charge during synthesis of biomacro-initiators |
| CN109232898A (zh) * | 2018-08-02 | 2019-01-18 | 张玲 | 一种具有抗凝血功能的聚酰亚胺新材料的制备方法 |
| CN111534458B (zh) * | 2020-04-13 | 2022-01-14 | 浙江工业大学 | 无色杆菌tbc-1及其在降解1,3,6,8-四溴咔唑中的应用 |
| CN113716982B (zh) * | 2021-08-24 | 2022-05-06 | 重庆云瑞肥业有限公司 | 一种食品垃圾回收用发酵制肥装置 |
Family Cites Families (81)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3710795A (en) | 1970-09-29 | 1973-01-16 | Alza Corp | Drug-delivery device with stretched, rate-controlling membrane |
| US4179337A (en) * | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
| US4002531A (en) * | 1976-01-22 | 1977-01-11 | Pierce Chemical Company | Modifying enzymes with polyethylene glycol and product produced thereby |
| EP0082481B2 (en) | 1981-12-23 | 1990-09-12 | Schering Corporation | Stabilised alpha-interferon formulations and their preparation |
| WO1985003934A1 (fr) * | 1984-03-06 | 1985-09-12 | Takeda Chemical Industries, Ltd. | Proteine modifiee chimiquement et son procede de preparation |
| GB8334102D0 (en) * | 1983-12-21 | 1984-02-01 | Searle & Co | Interferons with cysteine pattern |
| DE3572982D1 (en) | 1984-03-06 | 1989-10-19 | Takeda Chemical Industries Ltd | Chemically modified lymphokine and production thereof |
| DE3675588D1 (de) | 1985-06-19 | 1990-12-20 | Ajinomoto Kk | Haemoglobin, das an ein poly(alkenylenoxid) gebunden ist. |
| US4917888A (en) | 1985-06-26 | 1990-04-17 | Cetus Corporation | Solubilization of immunotoxins for pharmaceutical compositions using polymer conjugation |
| US4766106A (en) | 1985-06-26 | 1988-08-23 | Cetus Corporation | Solubilization of proteins for pharmaceutical compositions using polymer conjugation |
| EP0229108B1 (en) | 1985-06-26 | 1990-12-27 | Cetus Corporation | Solubilization of proteins for pharmaceutical compositions using polymer conjugation |
| JP2514950B2 (ja) * | 1986-03-10 | 1996-07-10 | エフ・ホフマン―ラ ロシユ アーゲー | 化学修飾蛋白質，その製造法および中間体 |
| US4894226A (en) * | 1986-11-14 | 1990-01-16 | Cetus Corporation | Solubilization of proteins for pharmaceutical compositions using polyproline conjugation |
| US5080891A (en) | 1987-08-03 | 1992-01-14 | Ddi Pharmaceuticals, Inc. | Conjugates of superoxide dismutase coupled to high molecular weight polyalkylene glycols |
| US5135919A (en) | 1988-01-19 | 1992-08-04 | Children's Medical Center Corporation | Method and a pharmaceutical composition for the inhibition of angiogenesis |
| US5116964A (en) * | 1989-02-23 | 1992-05-26 | Genentech, Inc. | Hybrid immunoglobulins |
| US5286637A (en) * | 1989-08-07 | 1994-02-15 | Debiopharm, S.A. | Biologically active drug polymer derivatives and method for preparing same |
| US5252714A (en) * | 1990-11-28 | 1993-10-12 | The University Of Alabama In Huntsville | Preparation and use of polyethylene glycol propionaldehyde |
| US5595732A (en) | 1991-03-25 | 1997-01-21 | Hoffmann-La Roche Inc. | Polyethylene-protein conjugates |
| US5281698A (en) | 1991-07-23 | 1994-01-25 | Cetus Oncology Corporation | Preparation of an activated polymer ester for protein conjugation |
| WO1993012145A1 (en) * | 1991-12-19 | 1993-06-24 | Baylor College Of Medicine | Pva or peg conjugates of peptides for epitope-specific immunosuppression |
| ZA933926B (en) * | 1992-06-17 | 1994-01-03 | Amgen Inc | Polyoxymethylene-oxyethylene copolymers in conjuction with blomolecules |
| US5382657A (en) * | 1992-08-26 | 1995-01-17 | Hoffmann-La Roche Inc. | Peg-interferon conjugates |
| US5262564A (en) | 1992-10-30 | 1993-11-16 | Octamer, Inc. | Sulfinic acid adducts of organo nitroso compounds useful as retroviral inactivating agents anti-retroviral agents and anti-tumor agents |
| US5298410A (en) * | 1993-02-25 | 1994-03-29 | Sterling Winthrop Inc. | Lyophilized formulation of polyethylene oxide modified proteins with increased shelf-life |
| US5359030A (en) * | 1993-05-10 | 1994-10-25 | Protein Delivery, Inc. | Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same, and method of making and using the same |
| US5681811A (en) * | 1993-05-10 | 1997-10-28 | Protein Delivery, Inc. | Conjugation-stabilized therapeutic agent compositions, delivery and diagnostic formulations comprising same, and method of making and using the same |
| US5874075A (en) * | 1993-10-06 | 1999-02-23 | Amgen Inc. | Stable protein: phospholipid compositions and methods |
| US5951974A (en) | 1993-11-10 | 1999-09-14 | Enzon, Inc. | Interferon polymer conjugates |
| ATE214940T1 (de) | 1993-11-10 | 2002-04-15 | Enzon Inc | Verbesserte interferon-polymerkonjugate |
| US5446090A (en) | 1993-11-12 | 1995-08-29 | Shearwater Polymers, Inc. | Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules |
| US5639725A (en) | 1994-04-26 | 1997-06-17 | Children's Hospital Medical Center Corp. | Angiostatin protein |
| US5730990A (en) * | 1994-06-24 | 1998-03-24 | Enzon, Inc. | Non-antigenic amine derived polymers and polymer conjugates |
| US5650234A (en) | 1994-09-09 | 1997-07-22 | Surface Engineering Technologies, Division Of Innerdyne, Inc. | Electrophilic polyethylene oxides for the modification of polysaccharides, polypeptides (proteins) and surfaces |
| US5824784A (en) * | 1994-10-12 | 1998-10-20 | Amgen Inc. | N-terminally chemically modified protein compositions and methods |
| US5738846A (en) * | 1994-11-10 | 1998-04-14 | Enzon, Inc. | Interferon polymer conjugates and process for preparing the same |
| FI972443L (fi) * | 1994-12-07 | 1997-06-09 | Novo Nordisk As | Polypeptidi, jonka allergeenisuus on vähentynyt |
| US5932462A (en) | 1995-01-10 | 1999-08-03 | Shearwater Polymers, Inc. | Multiarmed, monofunctional, polymer for coupling to molecules and surfaces |
| US5672662A (en) | 1995-07-07 | 1997-09-30 | Shearwater Polymers, Inc. | Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications |
| SE9503380D0 (sv) * | 1995-09-29 | 1995-09-29 | Pharmacia Ab | Protein derivatives |
| EP0856026A1 (en) * | 1995-10-19 | 1998-08-05 | Receptagen Corporation | Discrete-length polyethylene glycols |
| US5702717A (en) * | 1995-10-25 | 1997-12-30 | Macromed, Inc. | Thermosensitive biodegradable polymers based on poly(ether-ester)block copolymers |
| US5908621A (en) * | 1995-11-02 | 1999-06-01 | Schering Corporation | Polyethylene glycol modified interferon therapy |
| US5747639A (en) * | 1996-03-06 | 1998-05-05 | Amgen Boulder Inc. | Use of hydrophobic interaction chromatography to purify polyethylene glycols |
| AU5773798A (en) | 1997-01-29 | 1998-08-18 | Polymasc Pharmaceuticals Plc | Pegylation process |
| PL335721A1 (en) | 1997-03-05 | 2000-05-08 | Ribogene | Novel methods of screening serving the purpose of identifying the factors of selective hepatitis c virus replication inhibition |
| US5990237A (en) * | 1997-05-21 | 1999-11-23 | Shearwater Polymers, Inc. | Poly(ethylene glycol) aldehyde hydrates and related polymers and applications in modifying amines |
| US7642323B2 (en) * | 1997-11-06 | 2010-01-05 | Nektar Therapeutics | Heterobifunctional poly(ethylene glycol) derivatives and methods for their preparation |
| US6448369B1 (en) * | 1997-11-06 | 2002-09-10 | Shearwater Corporation | Heterobifunctional poly(ethylene glycol) derivatives and methods for their preparation |
| WO1999030727A1 (en) * | 1997-12-17 | 1999-06-24 | Enzon, Inc. | Polymeric prodrugs of amino- and hydroxyl-containing bioactive agents |
| US6180095B1 (en) * | 1997-12-17 | 2001-01-30 | Enzon, Inc. | Polymeric prodrugs of amino- and hydroxyl-containing bioactive agents |
| US5981709A (en) | 1997-12-19 | 1999-11-09 | Enzon, Inc. | α-interferon-polymer-conjugates having enhanced biological activity and methods of preparing the same |
| US5985263A (en) | 1997-12-19 | 1999-11-16 | Enzon, Inc. | Substantially pure histidine-linked protein polymer conjugates |
| US5965119A (en) * | 1997-12-30 | 1999-10-12 | Enzon, Inc. | Trialkyl-lock-facilitated polymeric prodrugs of amino-containing bioactive agents |
| EP1411075B1 (en) * | 1998-03-12 | 2008-07-02 | Nektar Therapeutics Al, Corporation | Method for preparing polymer conjugates |
| DK1421956T3 (da) * | 1998-04-28 | 2007-10-01 | Applied Research Systems | Polyol-IFN-beta-konjugater |
| US6703381B1 (en) | 1998-08-14 | 2004-03-09 | Nobex Corporation | Methods for delivery therapeutic compounds across the blood-brain barrier |
| DK1656952T3 (da) * | 1998-10-16 | 2014-01-20 | Biogen Idec Inc | Polyalkylenglycolkonjugater af interferon beta-1A og anvendelser deraf |
| MXPA01012815A (es) * | 1999-06-11 | 2003-06-24 | Shearwater Corp | Hidrogeles derivados de quitosana y poli(etilenglicol) o polimeros relacionados. |
| US6531122B1 (en) * | 1999-08-27 | 2003-03-11 | Maxygen Aps | Interferon-β variants and conjugates |
| US7144574B2 (en) * | 1999-08-27 | 2006-12-05 | Maxygen Aps | Interferon β variants and conjugates |
| AU6687000A (en) | 1999-08-27 | 2001-03-26 | Maxygen Aps | New interferon beta-like molecules |
| KR100653153B1 (ko) | 1999-12-22 | 2006-12-01 | 넥타르 테라퓨틱스 에이엘, 코포레이션 | 수용성 중합체의 입체장애 유도체 |
| US6413507B1 (en) * | 1999-12-23 | 2002-07-02 | Shearwater Corporation | Hydrolytically degradable carbamate derivatives of poly (ethylene glycol) |
| ATE516820T1 (de) * | 2000-09-29 | 2011-08-15 | Schering Corp | Pegyliertes interleukin 10 |
| TW593427B (en) * | 2000-12-18 | 2004-06-21 | Nektar Therapeutics Al Corp | Synthesis of high molecular weight non-peptidic polymer derivatives |
| US7053150B2 (en) * | 2000-12-18 | 2006-05-30 | Nektar Therapeutics Al, Corporation | Segmented polymers and their conjugates |
| ES2289091T3 (es) * | 2001-02-01 | 2008-02-01 | Biogen Idec Ma Inc. | Conjugados polimeros de neublastina y metodos para usar los mismos. |
| WO2002074806A2 (en) | 2001-02-27 | 2002-09-26 | Maxygen Aps | New interferon beta-like molecules |
| US7009033B2 (en) * | 2001-07-02 | 2006-03-07 | Polymer Source Inc. | Heterofunctional polyethylene glycol and polyethylene oxide, process for their manufacture |
| SI2939696T1 (sl) * | 2001-10-18 | 2016-06-30 | Nektar Therapeutics | Polimerni konjugati opioidnih antagonistov |
| IL162031A0 (en) * | 2001-11-20 | 2005-11-20 | Pharmacia Corp | Chemically-modified human growth hormone conjugates |
| US6916962B2 (en) | 2001-12-11 | 2005-07-12 | Sun Bio, Inc. | Monofunctional polyethylene glycol aldehydes |
| WO2003049699A2 (en) * | 2001-12-11 | 2003-06-19 | Sun Bio, Inc. | Novel monofunctional polyethylene glycol aldehydes |
| US6956135B2 (en) * | 2001-12-11 | 2005-10-18 | Sun Bio, Inc. | Monofunctional polyethylene glycol aldehydes |
| KR100488351B1 (ko) * | 2001-12-11 | 2005-05-11 | 선바이오(주) | 신규한 폴리에틸렌글리콜-프로피온알데히드 유도체 |
| US7041855B2 (en) * | 2001-12-11 | 2006-05-09 | Sun Bio, Inc. | Monofunctional polyethylene glycol aldehydes |
| HUE047557T2 (hu) * | 2002-01-18 | 2020-04-28 | Biogen Ma Inc | Polialkilén polimervegyületek és felhasználásuk |
| WO2004022630A2 (en) | 2002-09-09 | 2004-03-18 | Nektar Therapeutics Al, Corporation | Water-soluble polymer alkanals |
| PT1667708E (pt) * | 2002-12-26 | 2012-09-14 | Mountain View Pharmaceuticals | Conjugados de interferão-beta-1b e polietileno glicol apresentando uma potência biológica in vitro aumentada |
| US20110165122A1 (en) * | 2009-11-10 | 2011-07-07 | The Regents Of The University Of California | Method for targeted and sustained antiviral therapy |
-
2003
- 2003-01-17 HU HUE15203017A patent/HUE047557T2/hu unknown
- 2003-01-17 SI SI200332472A patent/SI1476181T1/sl unknown
- 2003-01-17 PL PL372728A patent/PL213322B1/pl unknown
- 2003-01-17 CA CA2753899A patent/CA2753899C/en not_active Expired - Lifetime
- 2003-01-17 DK DK03731987.8T patent/DK1476181T3/en active
- 2003-01-17 RS YU63504A patent/RS55578B1/sr unknown
- 2003-01-17 EP EP19203313.2A patent/EP3669887A1/en not_active Withdrawn
- 2003-01-17 HU HUE03731987A patent/HUE028163T2/en unknown
- 2003-01-17 DK DK15203017T patent/DK3025726T3/da active
- 2003-01-17 BR BRPI0306993A patent/BRPI0306993B8/pt not_active IP Right Cessation
- 2003-01-17 NZ NZ534708A patent/NZ534708A/en not_active IP Right Cessation
- 2003-01-17 MX MXPA04006855A patent/MXPA04006855A/es active IP Right Grant
- 2003-01-17 EE EEP200400105A patent/EE05509B1/xx unknown
- 2003-01-17 EP EP15203017.7A patent/EP3025726B1/en not_active Expired - Lifetime
- 2003-01-17 CZ CZ2004877A patent/CZ2004877A3/cs unknown
- 2003-01-17 EA EA200701386A patent/EA011829B1/ru not_active IP Right Cessation
- 2003-01-17 HU HU0500457A patent/HU230473B1/hu unknown
- 2003-01-17 JP JP2003561523A patent/JP2005526151A/ja active Pending
- 2003-01-17 SI SI200332604T patent/SI3025726T1/sl unknown
- 2003-01-17 ME MEP-2008-356A patent/ME00239B/me unknown
- 2003-01-17 ES ES03731987.8T patent/ES2566797T3/es not_active Expired - Lifetime
- 2003-01-17 UA UA20040706173A patent/UA82184C2/uk unknown
- 2003-01-17 ES ES15203017T patent/ES2774801T3/es not_active Expired - Lifetime
- 2003-01-17 EA EA200400962A patent/EA009783B1/ru active Protection Beyond IP Right Term
- 2003-01-17 SK SK310-2004A patent/SK3102004A3/sk not_active Application Discontinuation
- 2003-01-17 PL PL397261A patent/PL397261A1/pl unknown
- 2003-01-17 GE GEAP20038365A patent/GEP20074024B/en unknown
- 2003-01-17 ME MEP-356/08A patent/MEP35608A/xx unknown
- 2003-01-17 EP EP03731987.8A patent/EP1476181B1/en not_active Expired - Lifetime
- 2003-01-17 GE GEAP8365A patent/GEP20064024B/en unknown
- 2003-01-17 CN CNA038057972A patent/CN1630530A/zh active Pending
- 2003-01-17 PT PT152030177T patent/PT3025726T/pt unknown
- 2003-01-17 KR KR1020047011171A patent/KR100964411B1/ko not_active Expired - Lifetime
- 2003-01-17 CN CN2009102081892A patent/CN101700401B/zh not_active Expired - Lifetime
- 2003-01-17 CA CA2840490A patent/CA2840490C/en not_active Expired - Lifetime
- 2003-01-17 CA CA2473526A patent/CA2473526C/en not_active Expired - Lifetime
- 2003-01-17 AU AU2003210564A patent/AU2003210564B2/en active Active
- 2003-01-17 WO PCT/US2003/001559 patent/WO2003061577A2/en not_active Ceased
- 2003-01-17 CA CA2952488A patent/CA2952488C/en not_active Expired - Lifetime
-
2004
- 2004-07-14 IL IL163006A patent/IL163006A/en active Protection Beyond IP Right Term
- 2004-07-15 IS IS7353A patent/IS2989B/is unknown
- 2004-07-16 US US10/892,830 patent/US8017733B2/en active Active
- 2004-08-10 BG BG108839A patent/BG66525B1/bg unknown
- 2004-08-17 ZA ZA2004/06555A patent/ZA200406555B/en unknown
- 2004-08-17 NO NO20043422A patent/NO339857B1/no not_active IP Right Cessation
-
2009
- 2009-04-30 JP JP2009110274A patent/JP5275125B2/ja not_active Expired - Lifetime
-
2011
- 2011-09-12 US US13/230,080 patent/US8524660B2/en not_active Expired - Lifetime
-
2012
- 2012-07-05 JP JP2012151745A patent/JP2012255156A/ja active Pending
-
2013
- 2013-01-21 JP JP2013008426A patent/JP2013136756A/ja not_active Abandoned
-
2015
- 2015-07-02 JP JP2015133310A patent/JP6030717B2/ja not_active Expired - Lifetime
- 2015-08-26 NO NO20151082A patent/NO344612B1/no not_active IP Right Cessation
-
2016
- 2016-08-03 LU LU93162C patent/LU93162I2/fr unknown
- 2016-08-04 BE BE2016C040C patent/BE2016C040I2/fr unknown
- 2016-08-05 CY CY2016027C patent/CY2016027I1/el unknown
- 2016-08-11 NL NL300826C patent/NL300826I2/nl unknown
- 2016-08-12 FR FR16C0034C patent/FR16C0034I2/fr active Active
- 2016-08-18 HU HUS1600035C patent/HUS1600035I1/hu unknown
-
2017
- 2017-04-10 NO NO2017013C patent/NO2017013I2/no unknown
-
2020
- 2020-02-06 CY CY20201100115T patent/CY1122841T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2016027I1 (el) | Πολυμερικες ενωσεις πολυαλκυλενιου και χρησεις αυτων | |
| CY2018009I1 (el) | Παραλλαγες ανοσοσφαιρινων και χρησεις αυτων | |
| CY2021039I1 (el) | Θειενοπυριμιδινικες ενωσεις και χρηση τους | |
| DE60316445D1 (de) | Funktionalisiertes polymer und verbesserte vulkanisate daraus | |
| DE602004021904D1 (de) | Gyraseinhibitoren und deren verwendungen | |
| CY2012024I1 (el) | Υπο-ακετυλιωμενα και υπερ-ακετυλιωμενα μηνιγγοκοκκικα καψικα σακχαριδια | |
| DE60225204D1 (de) | Polymerelektrolyt und Hestellungsverfahren dafür | |
| NL1025404A1 (nl) | Pyrazolo-triazine verbindingen en gebruik daarvan. | |
| DK1378554T3 (da) | Hydrofile polymerkoncentrater | |
| DE60226865D1 (de) | Thermoplastische elastomerzusammensetzung | |
| DE60228825D1 (de) | Hochnukleierte thermoplastische gegenstände | |
| DE60326611D1 (de) | N und dergleichen | |
| NO20055568D0 (no) | Substituerte 1,4-diazepiner og anvendelser derav | |
| DE602004031607D1 (de) | Propylenpolymerzusammensetzung und verwendung davon | |
| ATE433448T1 (de) | Kondensierte heterocyclen und deren verwendungen | |
| DE60216345D1 (de) | Gummimischung und deren Verwendung | |
| DK1562918T3 (da) | Substituerede benzoxazinoner og anvendelser deraf | |
| DE60221013D1 (de) | Mehrschichtiger polymerfilm | |
| DE60309482D1 (de) | Polyethylenglykol-aldehydderivate | |
| DE60216283D1 (de) | Thermoplastische elastomerzusammensetzung | |
| DE60323517D1 (de) | Hybridisierungsnachweisverfahren und bioassay-vorr | |
| DE60230349D1 (de) | Verbesserte Polymerzusammensetzung | |
| DE60305774D1 (de) | Schnelle und flexible Bereichsüberprüfung | |
| DE60207362D1 (de) | Thermoplastische olefinelastomerzusammensetzung | |
| FI20010711L (fi) | Muovimateriaali |